Rua Bioscience Limited — Major Shareholding Notification 2020

Oct 22, 2020

DISCLOSURE OF BEGINNING TO HAVE SUBSTANTIAL HOLDING

Section 276, Financial Markets Conducts Act 2013

To NZX Limited (NZX)

and

To Rua Bioscience Limited

Date this disclosure made: 22 October 2020

Date on which substantial holding began: 22 October 2020

Substantial product holder(s) giving disclosure

Full name(s): Tailorspace Capital Limited ( TCL ) Tailorspace Limited

Ben Gough

Trevor Burt

Summary of substantial holding

Class of quoted voting products: ordinary shares in Rua Bioscience Limited (NZX Code: RUA)

Summary for: TCL, Tailorspace Limited, Ben Gough and Trevor Burt

For this disclosure:

• a) total number held in class: 11,129,375

• b) total in class: 140,012,225

• c) total percentage held in class: 7.949%

Details of relevant interests

Details for TCL

Nature of relevant interest(s): Registered holder and beneficial owner of the shares in Rua Bioscience Limited. For that relevant interest,–

• a) number held in class: 11,129,375

• b) percentage held in class: 7.949%

• c) current registered holder(s): TCL

• d) registered holder(s) once transfers are registered: Not applicable

For a derivative relevant interest, also –

• a) type of derivative: Not applicable

• b) details of derivative: Not applicable

• c) parties to the derivative: Not applicable

• d) if the substantial product holder is not a party to the derivative, the nature of the relevant interest in the derivative: Not applicable

Details for Tailorspace Limited

Nature of relevant interest(s): TCL is wholly owned by Tailorspace Limited and accordingly Tailorspace Limited has a relevant interest in TCL’s shares in Rua Bioscience Limited.

For that relevant interest,–

• a) number held in class: 11,129,375

• b) percentage held in class: 7.949%

• c) current registered holder(s): TCL

• d) registered holder(s) once transfers are registered: Not applicable

For a derivative relevant interest, also –

• a) type of derivative: Not applicable

• b) details of derivative: Not applicable

• c) parties to the derivative: Not applicable

• d) if the substantial product holder is not a party to the derivative, the nature of the relevant interest in the derivative: Not applicable

Details for Ben Gough

Nature of relevant interest(s): Ben Gough and Trevor Burt (in Trevor’s capacity as an independent trustee of the Ben Gough Family Trust with no beneficial interest) are trustees of the Ben Gough Family Trust and jointly hold the shares in Tailorspace Limited on behalf of the Ben Gough Family Trust. TCL is wholly owned by Tailorspace Limited and accordingly Ben Gough, in his capacity as trustee of the Ben Gough Family Trust, has a relevant interest in TCL’s shares in Rua Bioscience Limited.

For that relevant interest,–

• a) number held in class: 11,129,375

• b) percentage held in class: 7.949%

• c) current registered holder(s): TCL

• d) registered holder(s) once transfers are registered: Not applicable

For a derivative relevant interest, also –

• a) type of derivative: Not applicable

• b) details of derivative: Not applicable

• c) parties to the derivative: Not applicable

• d) if the substantial product holder is not a party to the derivative, the nature of the relevant interest in the derivative: Not applicable

Details for Trevor Burt

Nature of relevant interest(s): Ben Gough and Trevor Burt (in Trevor’s capacity as an independent trustee of the Ben Gough Family Trust with no beneficial interest) are trustees of the Ben Gough Family Trust and jointly hold the shares in Tailorspace Limited on behalf of the Ben Gough Family Trust. TCL is wholly owned by Tailorspace Limited and accordingly Trevor Burt, in his capacity as independent trustee of the Ben Gough Family Trust, has a relevant interest in TCL’s shares in Rua Bioscience Limited.

For that relevant interest,–

• a) number held in class: 11,129,375

• b) percentage held in class: 7.949%

• c) current registered holder(s): TCL

• d) registered holder(s) once transfers are registered: Not applicable

For a derivative relevant interest, also –

• a) type of derivative: Not applicable

• b) details of derivative: Not applicable

• c) parties to the derivative: Not applicable

• d) if the substantial product holder is not a party to the derivative, the nature of the relevant interest in the derivative: Not applicable

Details of transactions and events giving rise to substantial holding

Details of the transactions or other events requiring disclosure: Each of TCL, Tailorspace Limited, Ben Gough (in Ben’s capacity as a trustee of the Ben Gough Family Trust) and Trevor Burt (in Trevor’s capacity as an independent trustee of the Ben Gough Family Trust) became substantial product holders upon Rua Bioscience Limited’s ordinary shares being quoted on the NZX Main Board on 22 October 2020.

Additional information

Address(es) of substantial product holder:

TCL, Tailorspace Limited and Ben Gough: Level 4, 151 Cambridge Terrace, Christchurch Central, Christchurch, 8013, New Zealand

Trevor Burt: 58 Old Tai Tapu Road, Kennedys Bush, Christchurch, 8025, New Zealand

Contact details: Joshua Woo +64 9 309 1445 jow@lojo.co.nz

Nature of connection between substantial product holders: TCL is the registered holder of 11,129,375 shares in Rua Bioscience Limited and Tailorspace Limited, Ben Gough and Trevor Burt are each associated persons of TCL under section 12(1) of the Financial Markets Conduct Act 2013.

Name of any other person believed to have given, or believed to be required to give, a disclosure under the Financial Markets Conduct Act 2013 in relation to the financial products to which this disclosure relates: Rua Bioscience Limited

Disclosure has effect for purposes of directors’ and senior managers’ disclosure

Trevor Burt is also a director of Rua Bioscience Limited. This disclosure also constitutes disclosure for the purposes of the directors’ and senior managers’ disclosure obligations.

Certification

I, Brett Gamble, certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.